OBJECTIVE: We aimed to determine the effect of human SH2B1 variants on leptin and insulin signaling, major regulators of energy homeostasis, on the RNA level. METHODS: We analyzed the expression of infrequent alleles of seven SH2B1 variants (Arg67Cys, Lys150Arg, Thr175Ala, Thr343Met, Thr484Ala, Ser616Pro and Pro689Leu) in response to insulin or leptin cell stimulation. Two of these were identified in own mutation screens, the others were predicted to be deleterious or to serve as controls. The variants were analyzed in a homologous system of mouse hypothalamic cells. Changes in expression of downstream genes were measured. Student’s t-test for independent samples was applied and effect sizes using Cohen’s d were calculated. RESULTS: In 34 of 54 analyzed genes involved in leptin (JAK/STAT or AKT) signaling, variants nominally changed expression. The expression of three genes was considerably increased (p values ≤ 0.001: Gbp2b (67Cys; d = 25.11), Irf9 (689Leu; d = 44.65) and Isg15 (150Arg; d = 20.35)). Of 32 analyzed genes in the insulin signaling pathway, the expression of 10 genes nominally changed (p ≤ 0.05), three resulted in p values ≤ 0.01 ( Cap1 (150Arg; d = 7.48), Mapk1 (343Met; d = –6.80) and Sorbs1 (689Leu; d = 7.82)). CONCLUSION: The increased expression of genes in leptin (JAK/STAT or AKT) signaling implies that the main mode of action for human SH2B1 mutations might affect leptin signaling rather than insulin signaling.
OBJECTIVE: We aimed to determine the effect of humanSH2B1 variants on leptin and insulin signaling, major regulators of energy homeostasis, on the RNA level. METHODS: We analyzed the expression of infrequent alleles of seven SH2B1 variants (Arg67Cys, Lys150Arg, Thr175Ala, Thr343Met, Thr484Ala, Ser616Pro and Pro689Leu) in response to insulin or leptin cell stimulation. Two of these were identified in own mutation screens, the others were predicted to be deleterious or to serve as controls. The variants were analyzed in a homologous system of mouse hypothalamic cells. Changes in expression of downstream genes were measured. Student’s t-test for independent samples was applied and effect sizes using Cohen’s d were calculated. RESULTS: In 34 of 54 analyzed genes involved in leptin (JAK/STAT or AKT) signaling, variants nominally changed expression. The expression of three genes was considerably increased (p values ≤ 0.001: Gbp2b (67Cys; d = 25.11), Irf9 (689Leu; d = 44.65) and Isg15 (150Arg; d = 20.35)). Of 32 analyzed genes in the insulin signaling pathway, the expression of 10 genes nominally changed (p ≤ 0.05), three resulted in p values ≤ 0.01 ( Cap1 (150Arg; d = 7.48), Mapk1 (343Met; d = –6.80) and Sorbs1 (689Leu; d = 7.82)). CONCLUSION: The increased expression of genes in leptin (JAK/STAT or AKT) signaling implies that the main mode of action for humanSH2B1 mutations might affect leptin signaling rather than insulin signaling.
Authors: Patrick Tarnow; Anne Rediger; Harald Brumm; Petra Ambrugger; Eva Rettenbacher; Kurt Widhalm; Anke Hinney; Gunnar Kleinau; Michael Schaefer; Johannes Hebebrand; Gerd Krause; Annette Grüters; Heike Biebermann Journal: Obes Facts Date: 2008-06-20 Impact factor: 3.942
Authors: Anna-Lena Volckmar; Jie-Yun Song; Ivonne Jarick; Carolin Pütter; Maria Göbel; Lucie Horn; Christoph Struve; Katharina Haas; Nadja Knoll; Harald Grallert; Thomas Illig; Thomas Reinehr; Hai-Jun Wang; Johannes Hebebrand; Anke Hinney Journal: PLoS One Date: 2015-05-08 Impact factor: 3.240
Authors: Maren E Cannon; Kevin W Currin; Kristin L Young; Hannah J Perrin; Swarooparani Vadlamudi; Alexias Safi; Lingyun Song; Ying Wu; Martin Wabitsch; Markku Laakso; Gregory E Crawford; Karen L Mohlke Journal: G3 (Bethesda) Date: 2019-08-08 Impact factor: 3.154
Authors: Sergio De Salvatore; Laura Ruzzini; Umile Giuseppe Longo; Martina Marino; Alessandra Greco; Ilaria Piergentili; Pier Francesco Costici; Vincenzo Denaro Journal: BMC Med Genomics Date: 2022-05-19 Impact factor: 3.063